BSX
Boston Scientific Corp
43.90$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20.2% | 19.1% | 17.9% | 20.1% | 19.1% | 15.4% | 21.7% | 19.6% | 17.7% | 18.5% | 17.6% | 20.1% | |
| 3.5% | 1.8% | 1.1% | 1.0% | 0.7% | 0.7% | 5.6% | 6.0% | 2.9% | 2.5% | 1.1% | 4.7% | |
| 3.5% | 1.8% | 1.1% | 1.0% | 0.7% | 0.7% | 5.6% | 6.0% | 2.9% | 2.5% | 1.1% | 4.7% | |
| 7.0% | 7.0% | 8.1% | 8.1% | 7.7% | 6.0% | 5.0% | 5.5% | 6.1% | 6.3% | 6.5% | 6.7% | |
| 5.6% | 5.6% | 5.3% | 5.7% | 5.6% | 5.2% | 4.4% | 5.0% | 5.7% | 7.1% | 7.1% | 6.7% | |
| 9.0% | 8.2% | 9.0% | 8.9% | 8.5% | 6.8% | 6.8% | 7.0% | 8.7% | 9.4% | 9.5% | 10.3% | |
| 35.0% | 35.7% | 36.9% | 36.8% | 37.7% | 33.3% | 32.3% | 37.2% | 39.8% | 40.9% | 43.4% | 41.9% | |
| 33.3% | 34.2% | 32.5% | 30.7% | 30.3% | 25.8% | 19.2% | 19.0% | 18.2% | 17.1% | 17.0% | 16.1% | |
| 59.3% | 65.1% | 62.8% | 63.2% | 58.4% | 54.6% | 50.2% | 48.4% | 45.9% | 44.4% | 44.1% | 44.0% | |
| 13.3% | 13.4% | 19.8% | 29.7% | 25.1% | 15.9% | 12.0% | 13.3% | 11.7% | 14.0% | 16.2% | 12.5% | |
| 2.4% | 0.0% | 0.4% | 9.5% | 10.7% | 4.6% | 0.0% | 0.8% | 0.1% | 1.5% | 4.5% | 0.9% | |
| 1.6% | 1.2% | 2.5% | 2.8% | 1.7% | 1.8% | 1.7% | 2.5% | 2.7% | 2.7% | 2.4% | 2.6% | |
| 22.9% | 31.3% | 30.0% | 20.0% | 22.8% | 28.1% | 29.6% | 27.3% | 27.5% | 24.4% | 22.4% | 25.5% | |
| 40.7% | 34.9% | 37.2% | 36.8% | 41.6% | 45.4% | 49.8% | 51.6% | 54.1% | 54.9% | 55.3% | 55.5% | |
| -49.3% | -49.2% | -47.4% | -44.1% | -33.1% | -7.4% | -7.7% | -4.3% | -2.3% | 2.3% | 6.8% | 12.8% | |
| 8.0% | 7.4% | 7.6% | 7.3% | 6.7% | 4.6% | 4.6% | 4.4% | 4.4% | 4.2% | 3.8% | 3.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.